This executive and senior leader with over 20 years of experience at the FDA in broad-based medical and clinical policy, product development and regulatory review processes, clinical research, strategic communication, health equity, and national and global health issues takes on a new role.
Richardae (Chardae) Araojo is now listed as President of Araojo Advisory Group.
